2022
DOI: 10.1016/j.japh.2022.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 13 publications
(26 citation statements)
references
References 64 publications
1
23
2
Order By: Relevance
“…While the standing order for naloxone exists across Mississippi, this study showed that less than half of all Mississippi pharmacies had naloxone immediately available for consumers under the state standing order. The proportion of pharmacies with naloxone available in this census was lower than most others found in literature and notably even lower than what was found in a study examining naloxone access across community pharmacies within Alabama, which is a socioeconomically comparable state. Notably, independent pharmacies were the pharmacy type with the lowest proportion of naloxone available, which is consistent with other literature .…”
Section: Discussioncontrasting
confidence: 82%
“…While the standing order for naloxone exists across Mississippi, this study showed that less than half of all Mississippi pharmacies had naloxone immediately available for consumers under the state standing order. The proportion of pharmacies with naloxone available in this census was lower than most others found in literature and notably even lower than what was found in a study examining naloxone access across community pharmacies within Alabama, which is a socioeconomically comparable state. Notably, independent pharmacies were the pharmacy type with the lowest proportion of naloxone available, which is consistent with other literature .…”
Section: Discussioncontrasting
confidence: 82%
“…7,[10][11][12][13]16,19,20,23,24,26 Many of these measured outcomes related to potential access barriers, such as whether the medication is in stock or accessible without a prescription, price of the drug, pharmacists' willingness to dispense naloxone without a prescription or bill a patient's insurance plan when picking it up without a prescription, or whether they would dispense to an adolescent or third-party patient. 12 Others have utilized secret shopper methodology to assess whether pharmacists offered to counsel the patient and characterized the counseling provided (e.g., length, accuracy, and content) or to assess for evidence of stigma or bias during patient interactions. 17,23 Furthermore, some assessed changes in a study measure after an educational intervention or potentially practice-changing event (e.g., change in legislation and new guideline publication).…”
Section: Audit Settings and Outcomesmentioning
confidence: 99%
“…7 Furthermore, many community pharmacies, mainly independent, maintain a low level of naloxone in stock. [8][9][10] Reasons for pharmacists not dispensing naloxone at higher rates have been explored in the literature and highlight two key areas: a lack of training on the product, and a lack of confidence in communicating to patients about it. 11,12 One method to address these concerns would be via academic detailing.…”
Section: Introductionmentioning
confidence: 99%
“…While many pharmacists have utilized their state‐specific method to increase naloxone distribution, the amount of naloxone dispensed from pharmacies remains low 7 . Furthermore, many community pharmacies, mainly independent, maintain a low level of naloxone in stock 8–10 . Reasons for pharmacists not dispensing naloxone at higher rates have been explored in the literature and highlight two key areas: a lack of training on the product, and a lack of confidence in communicating to patients about it 11,12 .…”
Section: Introductionmentioning
confidence: 99%